Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT01480583
Title GRN1005 Alone or in Combination With Trastuzumab in Breast Cancer Patients With Brain Metastases
Acronym GRABM-B
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Angiochem Inc
Indications
Therapies
Age Groups: adult
Covered Countries USA


No variant requirements are available.